novo nordisk pfizer - Search News

Pfizer sues Metsera, Novo Nordisk

Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer

Novo Nordisk is raising the stakes in its push to outbid rival Pfizer and acquire the development-stage drugmaker Metsera.

· 6h · on MSN

Novo Nordisk Is Still Beating Pfizer in Battle Over Metsera

· 6h · on MSN

Pfizer is losing its fight with Novo Nordisk to get back in the obesity-drug game

· 11h

Pfizer and Novo Nordisk sweeten offers for Metsera as bidding war intensifies

Last week, Novo came over the top of an original Pfizer deal with Metsera with an up to $9bn offer for the biotech, sparking one of the most contentious bidding wars over a biotech in recent memory.

· 19h

Novo Nordisk CEO faces baptism of fire amid board shakeup, Pfizer fight

· 13h

Novo Nordisk’s weight-loss drug Wegovy could soon have a new sales outlet in the U.S.

Devdiscourse

Legal Showdown: Pfizer and Novo Nordisk Clash Over Metsera in Fierce Obesity Drug Battle

Pfizer and Novo Nordisk are in a heated legal and bidding war over Metsera, an obesity drug developer. Novo's $10 billion bid challenges Pfizer's prior deal with Metsera. Pfizer has sued to stop the process,

4don MSN

Pfizer Sues Seeking to Block Novo Nordisk’s Effort to Undo Weight-Loss Drug Deal

Drugmaker Pfizer on Friday sued obesity-drug developer Metsera and Novo Nordisk, seeking to block Metsera from terminating its multibillion-dollar merger deal with Pfizer after Novo Nordisk made an unsolicited takeover bid.

Pfizer, Novo Nordisk escalate bidding war for obesity drug developer Metsera

Pfizer on Tuesday raised its full-year profit forecast for the second quarter in a row as robust demand for its blockbuster blood thinner helped it post third-quarter earnings above expectations.